NEW YORK, April 14, 2023 /Health/– Here are some of the top health news stories from this week:
New COVID-19 variant BA.2 spreads rapidly in Europe and the US
US Supreme Court to hear case on abortion rights
WHO reports more than 1 million deaths from COVID-19
New study finds that obesity can increase risk of dementia
Researchers develop new drug that could treat Alzheimer’s disease
New COVID-19 variant BA.2 spreads rapidly in Europe and the US
A new COVID-19 variant, BA.2, is spreading rapidly in Europe and the US. BA.2 is a subvariant of Omicron, and it is believed to be more transmissible than the original Omicron variant. There is some evidence that BA.2 may be more resistant to vaccines, but more research is needed to confirm this.
US Supreme Court to hear case on abortion rights
The US Supreme Court is set to hear a case that could overturn Roe v. Wade, the landmark 1973 decision that legalized abortion nationwide. The case, Dobbs v. Jackson Women’s Health Organization, centers on a Mississippi law that bans most abortions after 15 weeks of pregnancy. If the Supreme Court overturns Roe v. Wade, it would be a major victory for anti-abortion activists and a major setback for abortion rights advocates.
WHO reports more than 1 million deaths from COVID-19
The World Health Organization (WHO) has reported that more than 1 million people have died from COVID-19. The WHO says that the true number of deaths from COVID-19 is likely much higher, as many deaths have gone unreported. The WHO also says that the COVID-19 pandemic is not over, and that countries need to continue to take measures to protect people from the virus.
New study finds that obesity can increase risk of dementia
A new study has found that obesity can increase the risk of dementia. The study, which was published in the journal JAMA Neurology, found that people who were obese were more likely to develop dementia than people who were not obese. The study’s authors say that the findings suggest that obesity should be considered a risk factor for dementia.
Researchers develop new drug that could treat Alzheimer’s disease
Researchers have developed a new drug that could potentially treat Alzheimer’s disease. The drug, called crenezumab, was developed by Eli Lilly and Company. Crenezumab is a monoclonal antibody that targets amyloid plaques, which are thought to be a major cause of Alzheimer’s disease. In a clinical trial, crenezumab was shown to slow the progression of Alzheimer’s disease. The drug is still in development, but it has the potential to be a major breakthrough in the treatment of Alzheimer’s disease.
These are just a few of the top health news stories from the past week. For more information on these and other health news stories, please visit the websites of the following organizations:
The Centers for Disease Control and Prevention (CDC)
The World Health Organization (WHO)
The American Medical Association (AMA)
The American Cancer Society (ACS)
The American Heart Association (AHA)